Cited by

• COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021.

  Achiron A, Dolev M, Menascu S, Zohar DN, Dreyer-Alster S, Miron S, Shirbint E, Magalashvili D, Flechter S, Givon U, Guber D, Stern Y, Polliack M, Falb R, Gurevich M. Achiron A, et al. Mult Scler. 2021 May;27(6):864-870. doi: 10.1177/13524585211003476. Epub 2021 Apr 15. Mult Scler. 2021. PMID: 33856242 Free PMC article.
• Immune thrombocytopenia following vaccination during the COVID-19 pandemic.

  Choi PY, Hsu D, Tran HA, Tan CW, Enjeti A, Chen VMY, Chong BH, Curnow J, Pepperell D, Bird R. Choi PY, et al. Haematologica. 2022 May 1;107(5):1193-1196. doi: 10.3324/haematol.2021.279442. Haematologica. 2022. PMID: 34435486 Free PMC article. No abstract available.
• Immune thrombocytopenia and COVID-19 vaccination: Outcomes and comparisons to prepandemic patients.

  Choi PY, Hsu D, Tran HA, Tan CW, Enjeti A, Chen VMY, Merriman E, Yong ASM, Simpson J, Gardiner E, Cherbuin N, Curnow J, Pepperell D, Bird R. Choi PY, et al. Res Pract Thromb Haemost. 2023 Jan;7(1):100009. doi: 10.1016/j.rpth.2022.100009. Epub 2022 Dec 13. Res Pract Thromb Haemost. 2023. PMID: 36531670 Free PMC article.
• Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021.

  Konu YR, Gbeasor-Komlanvi FA, Yerima M, Sadio AJ, Tchankoni MK, Zida-Compaore WIC, Nayo-Apetsianyi J, Afanvi KA, Agoro S, Salou M, Landoh DE, Nyansa AB, Boko E, Mijiyawa M, Ekouevi DK. Konu YR, et al. Arch Public Health. 2021 Nov 24;79(1):207. doi: 10.1186/s13690-021-00741-x. Arch Public Health. 2021. PMID: 34819146 Free PMC article.
• The impact of SARS-CoV-2 vaccination in Dravet syndrome: A UK survey.

  Clayton LM, Balestrini S, Cross JH, Wilson G, Eldred C, Evans H, Koepp MJ, Sisodiya SM. Clayton LM, et al. Epilepsy Behav. 2021 Aug 21;124:108258. doi: 10.1016/j.yebeh.2021.108258. Epub 2021 Aug 21. Epilepsy Behav. 2021. PMID: 34536735 Free PMC article.